All Industries

Nostra Terra CEO Paul Welch on company's new direction

Nostra Terra Oil and Gas Company PLC

Nostra Terra Oil & Gas Company PLC CEO Paul Welch talked with Proactive about the company's latest developments and strategic direction. Welch, who stepped up as CEO recently, shared insights into Nostra Terra’s focus on long-life conventional production in East Texas. Highlighting the primary asset, the Pine Mills Field, Welch discussed the potential to double production by revitalizing existing wells. Welch also explained the company’s divestment strategy, selling off assets in South and West Texas to concentrate resources and investments in East Texas. This move aims to enhance profitability and streamline operations. He emphasized the critical role of newly appointed board member James Newman, whose extensive experience in rejuvenating mature assets aligns perfectly with Nostra Terra’s goals. Welch noted the company sees the potential double production by turning on wells that have been shut in for some time. This strategic shift, along with updated company presentations and plans for future expansions, sets a promising trajectory for Nostra Terra. For more videos, visit Proactive's YouTube channel, give the video a like, subscribe to the channel, and enable notifications for future content. Contact Details Proactive North America Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

June 14, 2024 09:22 AM Eastern Daylight Time

Video

Seventy Ninth Resources acquires gold concessions from First Class Metals

The Seventy Ninth Group

Seventy Ninth Resources has announced the purchase of two gold concessions from the UK listed metals exploration company, First Class Metals PLC (“FCM”). The concessions, known as McKellar and Enable, are located in Marathon and Terrace Bay, in Ontario and represent Seventy Ninth Resources’ first gold concession acquisition in Canada since entering into a partnership with First Class Metals PLC. One of the concessions also includes base metals such as zinc and copper. The purchase of these two concessions comes as Seventy Ninth Resources intends to apply to list on the Toronto Stock Exchange Venture (TSXV). In 2021, Seventy Ninth Resources became the largest owner of natural resource concessions in West Africa, measured by the number of concessions under development, exploration, and management. Natalie Bellis CEO, Seventy Ninth Resources commented: “The concession acquisitions of McKellar and Enable are significant milestones and an exciting step towards building a pipeline of quality, data-verified exploration projects in Canada, particularly as we prepare to list on the TSXV. “Another exciting aspect is that one of the concessions includes base metals such as zinc and copper, which comes at a time when we are starting to explore opportunities around other metals alongside gold, including manganese and lithium. “This latest acquisition aligns with our long-term strategy to expand our mining exploration footprint across a number of territories across the globe. We look forward to building on our successful partnership with First Class Metals PLC. “ First Class Metals CEO, Marc. J Sale said: “I am pleased to announce the successful consolidation of our partnership with Seventy Ninth Resources through the sale of the Enable and McKellar properties. This achievement serves as validation for our model of identifying potential, adding value, and ultimately monetising the asset. In line with this strategy, FCM has recently expanded our portfolio by acquiring additional properties with significant potential, including the Kerrs Gold Project. “As we move forward, we are excited about the opportunity to collaborate further with Seventy Ninth Resources to develop their Canadian portfolio; alongside advancing and maximising the potential of theirs and FCM’s newly acquired assets.” Seventy Ninth Resources LimitedSeventy Ninth Resources holds a unique and advantageous position in the natural resources sector, specialising in the acquisition, management and development of desirable assets on a global scale. Since 2011, we’ve been operating in the Republic of Guinea. Our hands-on approach in-country has enabled us to pair local knowledge with industry expertise, working on the ground to identify desirable assets based on data-driven insight. With 15 employees in the operational in-country team, and through our initiatives to give back to the community, we’ve cultivated trusted relationships with local communities. Through these relationships, we’ve gained unique access to acquire land in areas with significant potential for gold, diamond and other precious resources. Environmental, social and governance (ESG) is at the heart of everything we do, and we have implemented several initiatives, including a collaboration with a local orphanage and a partnership with a non-governmental organisation to address issues related to mining in impacted communities. The developed Board and in-country team for Seventy Ninth Resources include world-class experienced geologists, field consultants, and ESG specialists, working alongside our industry-leading strategic partners, SRK Exploration Services and The MSA Group. Seventy Ninth Resources is also actively exploring mutually beneficial partnerships to further expand our existing portfolio of natural resource assets. Our recent partnership with First Class Metals (FCM) PLC, who have extensive Canadian, North Ontario land holdings, has enabled us to further expand our portfolio of natural resource assets globally. With our intention to list on the Toronto Stock Exchange Venture in the last quarter of 2024, Seventy Ninth Resources is committed to exploring opportunities to expand our natural resource offerings on a global scale.www.79thresources.com Contact Details Liam Britnell +44 7453 364820 liam@ambitiouspr.co.uk Company Website https://the79thgroup.co.uk/

June 14, 2024 09:22 AM Eastern Daylight Time

Lisata Therapeutics CEO encouraged by progress on pancreatic cancer trial

Lisata Therapeutics Inc

Lisata Therapeutics Inc. CEO David Mazzo talked with Proactive's Stephen Gunnion about the latest milestone in the company's Phase 1b/2a CENDIFOX trial. Mazzo shared that Lisata has completed patient enrollment for the pancreatic cancer cohorts in the phase 1B/2A clinical trial. This investigator-initiated trial, led by Dr Anup Kasi at The University of Kansas Cancer Center, is evaluating the safety and efficacy of certepetide (formerly LSTA1) in combination with FOLFIRINOX-based therapies for pancreatic, colon, and appendiceal cancers. Mazzo highlighted that the trial will enbable the collection of pre- and post-treatment biopsies of tumors. He also mentioned ongoing efforts to complete enrollment in two additional cohorts focusing on colorectal cancer and other tumor types, expecting these to be completed by the end of the year. Expressing his optimism, Mazzo noted the encouraging progress and enthusiasm surrounding the trial, which is drawing patients from the Kansas City area despite competition from other studies. He anticipates that preliminary results will be available by the end of the year, pending the timely processing of biopsies by external laboratories. Visit Proactive's YouTube channel for more videos, and don't forget to give the video a like, subscribe to the channel, and enable notifications for future content. Contact Details Proactive North America Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

June 14, 2024 09:19 AM Eastern Daylight Time

Video

Teads Unveils Next Generation Contextual and Identity Graph Built for the Premium Open Internet and CTV

Teads

Teads, the global media platform, today released the Teads Omnichannel Graph (OG), a proprietary tool extending contextual and audience-targeting capabilities into the CTV environment. Teads OG is built on the company’s understanding of what consumers read in editorial web environments and what consumers watch on connected TV. Using Teads OG, advertisers can plan, activate and measure cross-screen video campaigns to drive efficient reach on target, incrementality to linear TV and contextually aligned campaigns. Key capabilities of Teads OG include: Global Household & User-level Graph: Curated household and user graph enabling precision targeting and optimization across screens. The graph is based on a precise sample composed of over 50 Million CTV devices and over 100 Million users in 25 countries. Incremental Reach Planning & Measurement: Enabling TV buyers to efficiently extend their audience reach across screens. In addition to Teads’ content consumption data, Teads OG utilizes Automatic Content Recognition (ACR) data to target unexposed audiences. Granular CTV Contextual Signals: Deep contextual targeting capabilities based on standardized and enriched show-level information. Advanced contextual taxonomy is symmetrical to the Teads web contextual taxonomy for seamless omnichannel activation. Teads has a deep history of building unique capabilities to analyze contextual content consumption data on the open internet through direct integrations with premium publishers. Combining this contextual data with device and consumer behavior signals has served as a high-fidelity proxy for audience targeting through AI-based inference. These capabilities enable advertisers to activate media and reach audiences seamlessly with or without user identification with deep contextual targeting within editorial environments. “With Teads OG, we’re extending our knowledge of what people read into what content they watch and making that data actionable at scale across screens to drive better results,” said Jeremy Arditi, co-CEO of Teads. Teads expanded into omnichannel more than two years ago and has been delivering superior results for brands since launch. Since the beginning of 2024, Teads has delivered over 50 campaigns targeting and measuring incremental reach. In a campaign with Yokohama, Teads delivered brand lift using incremental reach planning and measurement. By leveraging cookieless strategies for the online video portion of the campaign and optimizing ad performance across multiple screens, the campaign achieved significant results, including a 27% cost savings, a 5.5-point increase in brand familiarity, and a 7-point lift in perception. "We wanted to create a stronger audience-centric approach for our campaign by expanding our understanding of individual performance impact. By utilizing Teads' innovative solutions, we unlocked exceptional outcomes that far exceeded our initial expectations," said Riley Mackey of Yokohama’s Agency, Charts + Darts. About Teads Teads operates a leading, cloud-based, omnichannel platform that enables programmatic digital advertising across a global ecosystem of quality digital media. As an end-to-end solution, Teads’ modular platform allows partners to leverage buy-side, sell-side, creative, data and AI optimization technologies. For advertisers and their agencies, Teads offers a single access point to buy the inventory of many of the world’s best publishers and content providers. Through exclusive global media partnerships, Teads enables advertisers and agencies to reach billions of unique monthly users in brand safe, responsible advertising environments, while improving the effectiveness and efficiency of digital ad transactions. Teads partners with the leading marketers, agencies and publishers through a team of 1,200+ people in 50 offices across more than 30 countries. Contact Details Kite Hill PR for Teads Alexandra Morrison teads@kitehillpr.com Company Website https://www.teads.com/

June 14, 2024 09:00 AM Eastern Daylight Time

Days After Successful IPO, Fly-E Rings The Closing Nasdaq Bell And Celebrates E-Two-Wheel Market’s Future

Benzinga

By Meg Flippin, Benzinga Ringing the opening or closing bell on the Nasdaq MarketSite is a rite of passage for a lucky few companies bestowed with that honor each year. It not only celebrates a company’s status as a public entity but showcases its strength in the market and with investors. Not to mention, it brings a little brand recognition. After all, the closing bell is broadcast on screens across the nation. Fly-E Group, Inc. (NASDAQ: FLYE), the maker of electric bikes, scooters, motorcycles and accessories, joined that elite club, with chairperson and CEO Andy Ou ringing the closing bell Wednesday. The gesture celebrated a successful startup that completed its initial public offering last week. It also comes at a time when the electric bike, scooter and motorcycle market is taking off. The global electric scooter market had a value of $24.67 billion last year and is predicted to reach $50.78 billion by 2032. Driving adoption is a push by governments around the world to curb emissions. With cities getting more crowded, hopping on an e-scooter or bike is not only greener, but a quick and easy way to get around. Fly-E Raises $9 Million From IPO In Fly-e’s IPO, the 2.25 million share offering was priced at $4 per share. The company, which raised $9 million in its IPO, granted underwriters a 30-day overallotment option to purchase an additional 337,500 shares at the IPO price, less underwriting discounts and commissions. Fly-e is using net proceeds from the offering to cover the purchase of inventory and production costs of its vehicles, the expansion of its retail stores, its technology, research and development initiatives, and for general corporate purposes. Started in 2018 and currently based in New York City, Fly-e is an electric vehicle company that is principally focused on designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand “Fly E-Bike”. The company’s product line currently consists of 21 e-motorcycle products, 21 e-bike products and 34 e-scooter products, which it sells both online and through a network of 39 retail stores mainly in the U.S. The stores are strategically positioned in major metropolitan U.S. markets. In addition, Fly-e is opening locations in South America and Europe. Fly-e plans to expand its footprint of stores to other densely populated metro areas with some of the proceeds from its IPO. To keep costs down, most of the company’s manufacturing is handled in its China-based factories and assembled in the U.S. The goal is to become a leader in the electric two-wheel transportation market. High-Flying And Profitable While Fly-e is a high-flying growth IPO, its financials are much more stable than the run-of-the-mill startups that find profitability elusive as they chase growth. Fly-e reported $1.2 million in net income for the first nine months of 2023. Revenue grew 46% in the same time frame. Gross margins are 39% and the company is EBITDA and net profit positive. Fly-e attributes its margin strength to its growing maintenance, service business and accessories sales. That should increase further, along with an uptick of in-use bike counts, the company reports. All of this should be welcome news to its investors since cash-burning IPOs are losing their luster. Fly-e demonstrates a company can be an early-stage growth stock and still show financial discipline. The e-scooter, bike and motorcycle market is taking off, and Fly-e is emerging as an important player. It's a story investors may want to pay attention to. After all, the Nasdaq MarketSite certainly is. Featured photo by Nick Chong on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

June 14, 2024 08:45 AM Eastern Daylight Time

Image

Candel Therapeutics' (NASDAQ: CADL) enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments

Candel Therapeutics

By Jeremy Golden, Benzinga Candel Therapeutics, Inc. (NASDAQ: CADL) is helping pioneer the next generation of viral immunotherapy by leveraging a data-driven approach to create new assets and further the development of existing drug candidates. Candel Therapeutics’ enLIGHTEN Discovery Platform integrates artificial intelligence-selected, therapeutic payloads into programmable vectors for delivery into the tumor microenvironment This tailored approach to discovery and development of new therapeutics has been designed to address the complexity of the tumor microenvironment and the diversity of the tumor response to existing treatments. Using large patient datasets, the enLIGHTEN™ Discovery Platform identifies druggable properties that correlate with clinical outcomes and predicts optimal therapeutic payload combinations in silico. Real-world testing of these predicted payload combinations is used to rapidly evaluate their therapeutic effects. Next, validated multigene payloads are integrated into one of Candel’s programmable viral vectors that are engineered with tunable features to address a specific unmet need in cancer treatment. The enLIGHTEN™ immunotherapy candidates represent a novel class of bespoke immunotherapies with each one tailored for a specific indication, disease stage, or rationally designed therapeutic combination therapy. First Experimental Candidate During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting and the International Oncolytic Virus Conference in November 2023, Candel presented the first experimental immunotherapy candidate from its discovery platform: Alpha 201-macro-1, an investigational,viral immunotherapy designed to activate innate immune surveillance. Preclinical data demonstrated that programmable, vector-mediated delivery of a novel gene payload designed to interfere with the CD47/SIRPα pathway significantly impede tumor growth when compared to systemic anti-CD47 antibody therapy in a mouse model of breast cancer. Soon afterwards, at the American Association for Cancer Research (AACR) Annual Meeting in April 2024, the company presented late-breaking data from its second immunotherapy candidate based on this platform: a therapeutic able to induce organized lymphocyte aggregates that resemble tertiary lymphoid structures (TLS) within solid tumors. Formation of TLS in tumors correlates with a positive response to immune checkpoint inhibitors and better prognosis. To date, there has not been any drug able to induce therapeutic TLS formation in cancer. The effects of Candel’s new immunotherapy candidate are based on two mechanisms. First, profiling of the biological response to the enLIGHTEN™ programmable vector demonstrated its potential to orchestrate changes in the tumor microenvironment, which bolster effective anti-tumor immune responses to immune checkpoint inhibitor treatment. Second, delivery of two unique payload combinations using this programmable vector resulted in TLS formation associated with monotherapy anti-tumor activity, and enhanced responses in combination with immune checkpoint inhibitor treatment in mouse models of solid tumors. Combining the immunological and oncolytic effects mediated by the viral vector with the biological activity of the transgene payloads results in a unique multimodal therapeutic able to induce the formation of TLS and inhibit the tumor. “With the enLIGHTEN Discovery Platform, we are leveraging our internal expertise and capabilities to design a new class of multimodal therapeutics that can overcome mechanisms of resistance present in the tumor microenvironment and address critical unmet needs for patients with cancer,” said Francesca Barone, M.D. Ph.D., CSO at Candel Therapeutics. “This platform has been designed for collaborations focused on rational combination therapies to induce disease remission in cancer. ” More exciting developments are on the horizon. Candel Therapeutics and the University of Pennsylvania are collaborating in a discovery partnership that will leverage enLIGHTEN™ programmable vectors with therapeutic payloads to potentially overcome barriers to Chimeric antigen receptor (CAR) T-cell therapies. Through the partnership, the University of Pennsylvania researchers – led by the Director of the T-Cell Engineering Lab within Penn’s Center for Cellular Immunotherapies, Neil C. Sheppard, Ph.D. – will explore the ability of Candel’s novel viral immunotherapies to enhance the effects of the university’s CAR T-cell therapies in solid tumor models. Featured photo by National Cancer Institute on Unsplash Candel is a clinical stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. Candel has established two clinical stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the lead product candidate from the adenovirus platform and is currently in ongoing clinical trials in non-small cell lung cancer (NSCLC) (phase 2), borderline resectable pancreatic cancer (phase 2), and localized, non-metastatic prostate cancer (phase 2 and phase 3). CAN-3110 is the lead product candidate from the HSV platform and is currently in an ongoing investigator-sponsored phase 1 clinical trial in recurrent high-grade glioma (HGG). Finally, Candel’s enLIGHTEN™ Discovery Platform is a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors. This article includes certain disclosures that contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, express or implied statements regarding the timing and advancement of development programs, including the timing and availability of additional data, key data readout milestones, including CAN-3110 in HGG; expectations regarding the potential benefits conferred by Fast Track Designation; expectations regarding the therapeutic benefit of its programs, including the potential for its programs to extend patient survival; and expectations regarding cash runway and expenditures. The words “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “target” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, those risks and uncertainties related to the timing and advancement of development programs; expectations regarding the therapeutic benefit of the Company’s programs; that final data from our pre-clinical studies and completed clinical trials may differ materially from reported interim data from ongoing studies and trials; the Company’s ability to efficiently discover and develop product candidates; the Company’s ability to obtain and maintain regulatory approval of product candidates; the Company’s ability to maintain its intellectual property; the implementation of the Company’s business model, and strategic plans for the Company’s business and product candidates, and other risks identified in the Company’s SEC filings, including the Company’s most recent Quarterly Report on Form 10-Q filed with the SEC, and subsequent filings with the SEC. The Company cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. The Company disclaims any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements. Any forward-looking statements contained in this press release represent the Company’s views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Aljanae Reynolds +1 617-916-5445 areynolds@wheelhouselsa.com Company Website https://www.candeltx.com/

June 14, 2024 08:30 AM Eastern Daylight Time

Image

The Biden administration just finalized a controversial new retirement rule — here are 5 things you need to know now

Moneywise

by Christy Bieber While we adhere to strict editorial guidelines, partners on this page also provide us earnings. Figuring out how to save for retirement is challenging. Unfortunately, if you want to turn to a professional for financial advice, that creates complications of its own. That's because there are many different kinds of professionals, like certified financial planners, investment advisers and financial advisers, and there are different regulations governing each one. Trusting the wrong person can have devastating consequences. The good news is the Biden Administration has stepped in to give investors more protection from conflicts of interest. The recently finalized Retirement Security Rule is aimed at ensuring these professionals actually work for the clients they serve. This rule isn't without controversy, though, as some argue it could actually make getting help harder. To understand how the rule might impact you, read on to find out five key facts. 1. More advisers will be considered fiduciaries A fiduciary is a person who is legally obligated to act in the best interest of the person whose money or property they are managing. They are held to a high standard so that people can trust them. You might assume anyone providing financial advice in a professional capacity is a fiduciary. That's not the case under the current rule. Right now, those offering one-time financial advice aren't considered fiduciaries, nor does the law require a fiduciary standard for those providing advice to workplace plan sponsors about 401(k) lineups or to anyone providing recommendations to purchase non-securities, such as real estate, fixed-income annuities, or commodities like gold. "The regulation closes the loophole for one-time advice," said the U.S. Department of Labor Fact Sheet, adding that financial services providers often have "a strong economic incentive" to recommend that investors roll their workplace retirement accounts into one of their institution's IRAs or annuities. The Retirement Security Rule broadens the definition of a fiduciary to include any financial service provider who is compensated to provide advice to individual retirement account owners, employers and plan fiduciaries. Sponsored Kiss Your Credit Card Debt Goodbye Millions of Americans are struggling to crawl out of debt in the face of record-high interest rates. A personal loan offers lower interest rates and fixed payments, making it a smart choice to consolidate high-interest credit card debt. It helps save money, simplifies payments, and accelerates debt payoff. Credible is a free online service that shows you the best lending options to pay off your credit card debt fast — and save a ton in interest. Explore better rates 2. It requires investment advisers to work for you The new rule also clarifies the exact duties advisers owe to you when acting in their fiduciary roles. Their obligations include providing advice that is: Prudent: It meets the professional standard of care. Loyal: Your interests are put first and advisers clearly disclose any potential conflicts of interest. Honest: The adviser isn't misrepresenting any information Fairly priced: Advisers cannot overcharge you or receive unreasonable or excessive compensation. 3. It could save Americans money When investment advisers act in the interest of consumers — rather than recommending investment products to earn a big commission — consumers can save. Exactly how much depends on what you're invested in. Morningstar, Inc. estimates that participants in workplace retirement plans could save as much as $55 billion in the coming ten years thanks to the Retirement Security Rule. It says over 80% of these savings would be experienced by small-plan participants, of which there are currently more than 20 million. Investors could save up to $5 billion annually that's lost to conflicted investment advice on fixed index annuities, according to the Council of Economic Advisers. Sponsored Discover the power of FreeCash – your ticket to easy money Dive into a world of rewards at FreeCash where earning cash is as simple as a click. No gimmicks, just real cash for your time. Join the community of earners today and watch your wallet grow effortlessly. Make Money Now 4. It could make accessing advice harder The rule sounds pretty great so far, so why is it controversial? A number of lawmakers and industry groups argue it could actually make accessing retirement advice more difficult for the average American. "It leaves retirement savers with fiduciary advisors as their only option for professional financial guidance," according to a statement by the American Council Of Life Insurers. "Fiduciaries typically work with clients with a minimum of $100,000 to invest, far more than most working-class Americans have in savings." Senator Joe Manchin also warned in a statement, "If allowed to go into effect, the rule has the potential to cause many West Virginians to actually lose access to investment advice due to how broadly the rule defines fiduciary. Hardworking West Virginians and Americans need protection, not uncertainty when it comes to their long-term financial security, and they certainly do not want or need the federal government further involved in their personal retirement decisions." 5. It takes effect in September of 2024 If you're hoping these new protections will keep you safe from bad advice, don't get on the phone to an adviser just yet. The rule takes effect on September 23, 2024 although it will be another year beyond that for all of the requirements to take effect. Once the rule is in place, you can feel more confident that the professionals you hire will act in your best interests. However, it's still important to research any provider you'll take advice from and to understand both how they charge and what their legal obligations are to you. The right adviser can make all the difference in building your financial security but ultimately it's your money on the line so doing your due diligence is crucial. Sponsored This 2 Minute Move Could Knock $500/Year off Your Car Insurance in 2024 Saving money on car insurance with BestMoney is a simple way to reduce your expenses. You’ll often get the same, or even better, insurance for less than what you’re paying right now. There’s no reason not to at least try this free service. Check out BestMoney today, and take a turn in the right direction. Contact Details Wise Publishing, Inc. Aaron Young +1 310-500-8744 aaron.young@wisepublishing.com Company Website https://moneywise.com/

June 14, 2024 07:00 AM Central Daylight Time

Image

Elon Musk Boosts DOGE, Declares He Knows Dogwifhat. Raboo Surges 60%

Total Media

Elon Musk’s recent endorsement of DOGE and mention of Dogwifhat have sent ripples through the crypto market. Meanwhile, Raboo is currently in its fourth stage of presale, boasting a 60% increase since Stage 1. With over $1.7 million raised, 8,000 registered members, and 2,500 token holders, Raboo is gaining traction. Priced at just $0.0048, analysts predict Raboo will surge 100x on launch day and 233% during the presale. Let's explore why Raboo is poised to compete with top cryptocurrencies like Dogecoin. Elon Musk’s influence boosts Dogecoin Elon Musk’s tweets have consistently impacted Dogecoin (DOGE). In 2024, Musk's endorsements had driven a 68% surge in DOGE's price. A recent tweet by Musk honoring Kabosu, the original dog behind the Dogecoin meme, caused a bullish trend. Following his post, DOGE rose by nearly 5%. Despite a brief hike in social volume and dominance, both metrics have since dropped. The Dogecoin price remains volatile, influenced heavily by Musk’s actions. While Musk’s impact on DOGE is undeniable, the future trajectory of Dogecoin price is uncertain. Musk's influence propels Dogwifhat Elon Musk mentioned Dogwifhat during a live stream on X, causing an immediate price rally for the meme coin. The Solana-based WIF soared despite the overall bearish market trend. Musk's acknowledgment, even with a mispronunciation, sent the crypto community into a frenzy. The WIF price jumped, showcasing Musk's significant impact on cryptocurrencies. Historically, Musk's endorsements, like those for Dogecoin (DOGE), have led to major price surges, and WIF appears to be the latest beneficiary. Before Musk’s mention, WIF was struggling, but his declaration defied the market downturn, however since then WIF has seen a drop in price. This event highlights Musk's unparalleled influence in the crypto space, marking the first time he publicly acknowledged a meme coin other than DOGE. Raboo skyrockets: What’s behind the 60% surge? Raboo ($RABT) is making waves as a top cryptocurrency to buy in 2024. The significant gains during the presale have already created buzz and attracted early investors. This momentum is likely to continue, driving interest as the project progresses. Investors are keen to capitalize on early gains, contributing to Raboo's rapid price increase. Raboo's community-driven approach is a key factor. By fostering a large, engaged community of meme enthusiasts, Raboo enhances user engagement and loyalty. This organic growth through word-of-mouth and social sharing boosts its popularity. Raboo’s self-evolving AI technology allows users to participate in meme-generating contests, keeping it dynamic and engaging. This innovation differentiates Raboo from other meme coins and attracts tech-savvy users and investors. Raboo also offers staking options and a token-burning mechanism, providing long-term value and incentives for holding the token. These features appeal to investors looking for stability and returns. The upcoming launch of an NFT collection adds to Raboo's allure. Integrating NFTs can attract enthusiasts and collectors, further expanding its user base. Raboo’s innovative community-driven approach, staking options, NFT integration, and AI-based Rabooscan tool all contribute to its rising popularity and potential for future growth. Raboo is in the fourth stage of its presale. $RABT is currently priced at $0.0048, increasing by 60% since Stage 1. The presale has raised nearly $2 million, indicating strong investor interest. Analysts predict a 233% growth during the presale and a potential 100x increase on launch day. Raboo aims to join the top 20 cryptocurrencies by market cap, positioning itself to compete with popular tokens like Shiba Inu, Dogecoin, and Pepe. Conclusion Elon Musk's influence continues to drive DOGE and spark interest in Dogwifhat. Meanwhile, Raboo is making significant strides in its presale, with rapid sales highlighting strong investor enthusiasm. With its price up 60% since Stage 1 and predictions of a 100x surge on launch day, this is an excellent limited-time opportunity. Don’t miss out—join the Raboo presale today and secure your stake in this rising star of the crypto world. You can participate in the Raboo presale here. Telegram: https://t.me/RabootokenPortal Twitter: https://twitter.com/Raboo_Official Contact Details Total Media Solutions media@Totalsolutionspr.io

June 14, 2024 07:00 AM Eastern Daylight Time

Image

All Industries

Nostra Terra CEO Paul Welch on company's new direction

Seventy Ninth Resources acquires gold concessions from First Class Metals

Lisata Therapeutics CEO encouraged by progress on pancreatic cancer trial

Teads Unveils Next Generation Contextual and Identity Graph Built for the Premium Open Internet and CTV

Days After Successful IPO, Fly-E Rings The Closing Nasdaq Bell And Celebrates E-Two-Wheel Market’s Future

Candel Therapeutics' (NASDAQ: CADL) enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments

The Biden administration just finalized a controversial new retirement rule — here are 5 things you need to know now

Elon Musk Boosts DOGE, Declares He Knows Dogwifhat. Raboo Surges 60%

Top Tax Question Answered by Republic Tax: Why Hire a Professional Tax Attorney to Eliminate IRS Tax Debt